AC Immune SA is a Swiss biopharmaceutical company that focuses on neurodegenerative diseases, including Alzheimer’s disease. With a diverse pipeline of therapeutic candidates, the company utilizes innovative approaches to target and treat these debilitating conditions.
Notification